<DOC>
	<DOC>NCT02179606</DOC>
	<brief_summary>This study is to verify that Dermalax Implant Plus is not inferior to the reference device, RestylaneÂ® Sub-Q, in terms of efficacy and safety in the correction of nasolabial folds</brief_summary>
	<brief_title>Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1. Male or female subjects no younger than 30 and no more than 75 years of age. 2. Subjects who scored 3 or 4 on the Wrinkle Severity Rating Scale (WSRS) and want to improve the appearance of their nasolabial folds (the subject does not need to have the same score on both sides.*) *The scores need not to be same on both sides, but the two nasolabial folds should have symmetry in the range of 34. 3. Subjects who have symmetric nasolabial folds. 1. Subjects who received an antithrombotic agent within 2 weeks prior to screening (with the exception of low dose Aspirin less than 300 mg/day) 2. Subjects who have a history of bleeding disorder. 3. Subjects who have received calcium hydroxyapatite, CaHA injection in nasolabial area.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>